Enter assignee name

Forward Citations = 6

Loading Chart...

9 inventors (with patents filed for the assignee):

Samuel Clark (10 out of 11 patents)

Matthew Duncton (4 out of 42 patents)

Matthew Alexander James Duncton (1 out of 5 patents)

4. Jose Ángel Morales García (1 out of 1 patent)

5. Jordi Riba Serrano (1 out of 1 patent)

6. Ana Maria Perez Castillo (1 out of 1 patent)

7. Sam Clark (1 out of 1 patent)

8. Kenneth Wengler (1 out of 1 patent)

9. Guillermo Horga Hernandez (1 out of 1 patent)

12 patents: Sort by Forward Citations

1. 12612364 - Salts and solid forms of 4-hydroxy--diisopropyltryptamine hemi-glutarate and hemi-succinate (2026-04-28),

2. 12577222 - Phenethylamine compounds salts, polymorphic forms and methods of use thereof (2026-03-17),

3. 12435036 - Salts and solid forms of (R)-1-(5-methoxy-1H-indol-1-yl)-n,n-dimethylpropan-2-amine (2025-10-07),

4. 12319652 - Salts and solid forms of (R)-1-(5-methoxy-1H-indol-1-yl)-N,N-dimethylpropan-2-amine (2025-06-03),

5. 12269818 - Analogs of xanomeline (2025-04-08),

6. 12234216 - Isotopologues salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereof (2025-02-25),

7. 12079960 - Systems, devices, and methods for harmonization of imaging datasets including biomarkers (2024-09-03),

8. 11958821 - Phenethylamine compounds salts, polymorphic forms and methods of use thereof (2024-04-16),

9. 11905295 - Solid forms of tabernanthalog monofumarate salt for treating neurological disorders and/or psychiatric disorders (2024-02-20),

10. 11866408 - N,N-dimethyltryptamine and related psychedelics and uses thereof (2024-01-09),

11. 11851452 - Psilocybin and O-acetylpsilocin, salts and solid state forms thereof (2023-12-26),

12. 11723894 - Combination product for the treatment of neurological and/or psychiatric disorders (2023-08-15),

Terran Biosciences, Inc. is a biotechnology company based in New York, specializing in the development of innovative therapies for neurological and psychiatric disorders. The organization focuses on leveraging advanced research in neuroscience and pharmacology to create novel treatments aimed at improving patient outcomes. With a commitment to scientific excellence, Terran Biosciences is dedicated to addressing unmet medical needs through its cutting-edge research and development initiatives.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

12 Patents

#604 in New York, NY

#1,485 in New York

#25,540 in US

#48,129 in the World

New York, NY, United States of America

Terran Biosciences, Inc.